Dr. Sigal’s Center of Excellence
“I am excited to launch a phase 3 clinical trial with my colleagues to establish D’OXYVA’s safety and efficacy profile and help patients with diabetic foot ulcers.”
–Felix Sigal, DPM
Register to participate in the Phase 3 trial with diabetic foot ulcers.
About Dr. Felix Sigal, DPM
Dr. Felix Sigal graduated from California State Univeristy of Northridge and California College of Podiatric Medicine.
He then completed his Podiatric Residency training at LAC/USC General Hospital.
After completing his surgical training, Dr. Sigal went into private practice in Los Angeles. His practice is focused on wound care, diabetic limb salvage and clinical research.
Dr. Sigal is currently on staff at St. Vincent Medical Center and California Hospital Medical Center.
Dr. Sigal resides in San Fernando Valley with his wife and his two children. In his free time, he enjoys fishing, boating, traveling and spending time with his family.
About the Clinical Trial
We are excited to inform you about this unique opportunity that Circularity recently has confirmed Dr. Sigal’s prominent clinic in Los Angeles, CA as part of its pivotal Phase 3 multi-center, multi-country human clinical trials for rapid treatment and closure of diabetic foot ulcer wounds and as one of its centers of excellence.
This further secures Circularity’s ambitions to obtain updated FDA-clearance on its platform patented and patent pending FDA-approved drug (pharma-CO2) together with its patented non-invasive transdermal drug delivery systems even sooner than originally planned on a fast-track FDA program in several countries at the same time.
Every case completed and publicized each month and quarter is expected to generate enough buzz so we can spread the news of D’OXYVA’s power to ever-more suffering people in need.